Seasoned Technology Executives with a Passion for Social Entrepreneurship.



Seasoned Technology Executives with a Passion for Social Entrepreneurship.

Management Team



Rick Hennessey is an accomplished entrepreneur, angel investor, and a business advisor. He founded and successfully sold several businesses. He speaks globally at technology conferences and sits on several boards and advisory committees. Before joining BeneSol, Rick was the CEO of Cequint, Inc. which he sold to TNS, Inc. for over $100 million in 2010. Prior to Cequint, Rick was the CEO of Dwango Wireless. Rick entered Dwango through the acquisition of his firm Over-The-Air Wireless. Prior to OTA, Rick was founder and CEO of Sustainable Group, Inc. (Sold Dec. 2008 to a Seattle based Green Investment Consortium), Eversio Technologies (Sold April, 2008 to BCW, Inc.), Eversio Mobile (Sold in 2004 to Executive Wireless, Inc.) and Syndeo Systems (Merged in 2001 to Covault, Inc.). Rick has been successfully building early stage businesses in high growth markets for 20 years. In each of the markets Rick has tackled, he has embraced the industry’s community by being involved in industry committees, political initiatives and by speaking at conferences.


Alexander Moffat brings 20 years of experience as a team leader, engineer, software developer and entrepreneur. He comes from the background of a profitable small business owner in Manhattan, having spearheaded numerous successful innovations in his industry including the areas of software development and technological/mechanical invention. He has 12 years’ experience in software design, engineering, phototherapy device development and spectrum analysis. His understanding of photobiology and optical engineering has led to many unique inventions yielding several patents. Alexander is uniquely poised to unite the many aspects of BeneSol’s project and guide the right team to bring the project to fruition.


Bob Wise is a high-tech executive who has held senior executive roles with several Silicon Valley companies including Nuance, USWeb, and Novell. Prior to joining beneSol, Bob was the President of Nuance’s Healthcare Division where his team built clinical documentation systems used by physicians worldwide.  During his tenure at Nuance, he grew the division to $350 million in annual revenue with 2000 employees in eight countries. Previously Bob was a key participant in taking two companies public, has raised hundreds of millions in venture funding, and has served on multiple public and private boards.  In addition to his duties as CFO; he is a Director for Kitsap Bank a billion dollar community bank headquartered on the the Olympic Peninsula.


Technology executive with over 20 years' experience helping teams build world class consumer experiences in mobile, web, retail, health and energy space. Sen was Head of Technology at Cardfree, announced as Best Mobile Start-up of 2015 at CES, where he led development of scalable platform and launched Taco Bell Mobile Ordering, Online Ordering, and Dunkin Donuts On-The-Go-Ordering apps. While at Starbucks, Sen was the lead architect and principal engineer for key initiatives including NowPlaying,, Starbucks Rewards, Social Gifting and Starbucks Mobile application. He was one of the founders of a mobile ordering company, which won grand-prize at PayPal X challenge and launched in professional baseball and soccer venues. Sen brings a passion for technology, particularly the digital intersection of social, mobile, commerce and health.


Linda Cox began her career as a Clinical Physiologist working in Harvard Medical School institutions such as Beth Israel Deaconess Medical Center and Massachusetts General Hospital. She transitioned into the technology sector, becoming a product manager and clinical advocate for burgeoning medical device companies.

Linda’s career in technology spans 18 years as a director and consultant for projects inclusive of medical devices, wireless medical systems, handheld wireless communication systems, HIPAA complaint cloud based systems, custom software applications, RF and cellular communications and user interface design. She has extensive experience working with Class II FDA regulated products utilizing embedded algorithms. Many of the products and services she has managed have been considered disruptive technologies in the marketplace and, as such, have required unique approaches to development and marketing or positioning. Her corporate experience ranges from start-up through IPO, managing several consecutive product life cycles.    


Keith has 33 years of experience bringing complex machines to market. Keith has managed many hardware engineering and design projects for companies like Tektronix, Welch Allyn, and Zoll Medical. Over those years he has brought a breadth of products to market ranging from x-box consoles, monitors for aviation, prescription medical dispensers and lifesaving defibrillators to name a few. The products Keith has developed have helped people do many important things such as play, fly, test and live better lives.


Board of Directors



Chris is a co-founder and Managing Director of Ackerley Partners, LLC, a private investment company focused on the media and entertainment sectors. Prior to founding Ackerley Partners in 2002, Chris was the President of The Ackerley Group, Inc. (NYSE: AK) where he oversaw the daily operations of the national media and entertainment company. He served in a variety of roles for the company for more than 15 years, and was also a member of the company’s board of directors. Mr. Ackerley successfully led the merger of The Ackerley Group, Inc. with Clear Channel Communications, Inc. (NYSE: CCU) and led the negotiations and completion of The Ackerley Group’s sale of the Seattle SuperSonics and the Seattle Storm to The Basketball Club of Seattle led by Starbucks Chairman and CEO – Howard Schultz.

Chris began his career in the Capital Markets Group at Bank of America in London, England. He has and continues to serve as a director or advisor to a number of corporate boards including WashingtonTrust Bank, Limeade, Inc., The Four Seasons – Seattle, Concure Oncology, and Dyne, Inc. Chris has been involved with many civic and community organizations including the Pacific Science Center, the Downtown Seattle Association and Lakeside School. He also serves as a Vice-President of their family foundation – The Ginger and Barry Ackerley Foundation. In 2001, Mr. Ackerley was recognized by the Puget Sound Business Journal as one of the region’s most influential “40 Under 40” business leaders and in 2004, he was the recipient of the inaugural Outstanding Alumni Board Member Award by Seattle Works for his many contributions to the Seattle community. In 2007, he was inducted into the Hall of Honor for the Beta Phi Chapter of The Sigma Chi Fraternity.


Brett is a seasoned entrepreneur, investor and business executive possessing extensive experience in both the private and corporate arenas. With nearly two decades leading companies in the healthcare information and services industry, he has brought to market new ways to help healthcare organizations succeed and thrive in a dramatically changing marketplace.

Brett has built his career on the development and delivery of innovative solutions for hospitals and other healthcare-focused organizations—all for the purposes of reducing costs, increasing productivity and enhancing the quality of patient care. His market insights have been honed by close collaboration with senior executives at many of the world’s most respected medical institutions and leading healthcare technology innovators.

Currently Brett leads his Orlando based real estate development company, which is dedicated to assisting hospitals and physicians proactively identify and realize physical growth opportunities in the ever changing and complex healthcare marketplace. The company creates objective driven solutions that align all stakeholders and helps them better serve their communities through infrastructure and service line expansion. Previously, he was co-founder and President of Automated Document Solutions (ADS). Under his leadership, ADS introduced improved accuracy and cost-efficiency in the way patient records and billing is managed for hospitals and clinics. ADS merged with IOD, Inc. of Green Bay, Wisconsin in December 2010, and was sold to a strategic buyer in July 2014.

Brett serves on various industry boards and advisory committees and remains closely connected to the rapidly evolving healthcare market. He and his wife Peggy are active in a variety of community organizations and activities, including many with their two children. Brett holds a Bachelor of Science degree in Business Administration from the University of Central Florida.


In 1977, Woody Howse and Thomas Cable formed Cable & Howse Ventures, an early stage venture capital firm focused on technology. This company managed five venture capital partnerships with an aggregate capitalization of $160 million and invested in 103 companies. In 1982, Woody also participated in the founding of Cable, Howse and Ragen, investment banking and stock brokerage firm. Woody has served as a corporate director and advisor to various public, private and non-profit enterprises. He served on the board of the National Venture Capital Association and is past President of the Stanford Business School Alumni Association. He currently serves on the boards of directors for BSQUARE Corporation (NASDAQ: BSQR), Capstone Therapeutics, Inc (OTCQB:CAPS), Formotus, Inc and Stella Therapeutics, Inc.


Ralph Pascualy, M.D., oversees Swedish Medical Group (SMG), the physician division of Swedish Health Services that employs more than 900 providers across nearly 110 primary care and specialty care clinics throughout the Greater Seattle area. He provides vision, broad leadership and strategic management for all aspects of the physician practices and services. He also oversees the Swedish post-acute care division. In this role, he evaluates ways we can continually improve the value of our care model. The intent is to maximize our resources for the benefit of patients, families and caregivers. With more than 25 years of successful clinical, business, and administrative healthcare experience in the Seattle area, including at Swedish, Dr. Pascualy brings a keen understanding of the healthcare industry and its future direction.

Dr. Pascualy is a nationally recognized Sleep Medicine specialist who is board certified in Sleep Medicine and who currently appeared on the 2012 list of “Top Doctors” in Seattle Metropolitan magazine. He built the Swedish Sleep Medicine Institute into the leading sleep program in the western United States, beginning with its inception at Providence Medical Center in 1984. He is a former recipient of the distinguished William C. Dement Award in Sleep Disorders Medicine and has spoken and written widely on the topic of sleep disorders. Dr. Pascualy also is a diplomat of the American Boards of Neurology and Psychiatry and a clinical assistant professor for the Department of Psychiatry at the University Of Washington School Of Medicine. He earned his bachelor’s degree from Columbia University and his medical degree from Stony Brook University School of Medicine before doing his internship and residency through the University Of Washington School Of Medicine. He completed a Sleep Disorders Fellowship at Stanford University Sleep Medicine in Palo Alto, California.


Medical Advisors



William B. Grant has a Ph.D. in physics from the University of California, Berkeley (1971). He had a 30-year career in atmospheric sciences with an emphasis on laser remote sensing of atmospheric constituents such as ozone and aerosols, with positions at SRI International (1973-79), the Jet Propulsion Laboratory/California Institute of Technology (1979-89) and NASA Langley Research Center (1989-2004). He turned to health research in 1996, publishing the first paper linking diet to risk of Alzheimer’s disease in 1997, followed by studies of sugar, fat and coronary heart disease in 1998, and animal products and cancer risk in 1998. In 1999 he turned his attention to the role of solar ultraviolet-B exposure in reducing risk of many types of cancer through production of vitamin D in 2002. After retirement from NASA in 2004, he moved to San Francisco and formed the nonprofit organization Sunlight, Nutrition and Health Research Center (, where he spends most of his time studying the role of solar UVB exposure and vitamin D in reducing risk of cancer and many other types of disease. He also investigates the role of diet in risk of chronic diseases. He has about 300 health publications listed at , of which 210 are related to vitamin D, with 78 of these also on ultraviolet radiation and human health, and 41 to diet and disease.


Benjamin Lynch, ND received his Cell and Molecular Biology, BS from the University of Washington and his ND, with emphasis in Environmental Medicine, from Bastyr University. His passion for identifying the cause of disease directed him towards nutrigenomics and is one of the World’s top experts in methylation dysfunction. Currently, he researches, writes and presents worldwide on the topic of MTHFR and methylation defects. You may learn more about Dr. Lynch and his work at Dr. Lynch is also the president & CEO of, a company oriented towards disease prevention and health promotion. He lives in Kirkland, WA with his wife, Nadia, and three boys, Tasman, Mathew and Theodor.


Anne McTiernan, Ph.D., M.D. focuses her research on identifying ways to prevent new or recurrent cancer with a particular emphasis on weight control, physical activity, and chemoprevention. She received her MD in Internal Medicine from New York Medical College in 1989, and her PhD in Epidemiology from the University of Washington in 1982.

Dr. McTiernan is the Principal Investigator of the Komen-funded ViDA randomized controlled trial which is testing the effects of vitamin D vs. placebo on weight and breast cancer biomarkers in women undergoing a weight loss program. She is the Principal Investigator on numerous other studies involving exercise and lifestyle and their effects of various forms of cancer, including breast cancer and colon cancer. She was a member of the 2008 U.S. Department of Health and Human Services Physical Activity Guidelines Advisory Committee. Since 2010 she has been a Komen Scholar, and in 2012 she received a Citation Award from the American College of Sports Medicine for her research contributions on physical activity and health.


Specialty Advisors



Tina Valbh, RPh, a renowned thought leader in the specialty pharmacy industry, believes in enhancing the accessibility, quality and efficiency of care to patients, providers and drug manufacturers around the globe. For nearly two decades, Tina has focused on advanced research, development and care delivery of high touch biopharmaceuticals.

Tina has a significant background of developing clinical protocols for the management of patients with complex conditions. Her responsibilities have included the creation and implementation of drug safety programs; design of therapy adherence and persistence improvement programs for patients and physicians; and project management and timeline development for new drug launches. She has also performed the design of systems and processes to optimize clinical data capture; analysis of disease management outcomes; development of clinical education and training programs; design of compliance programs and procedures; and management of FDA registration trials.

Tina is an Expert Advisor on various for Advisory Committee’s at Axium Healthcare and a National Association of Specialty Pharmacy Committee Member in Trade Relations. She served as voting member on the FDA Antiviral Advisory Board Panel reviewing NDA applications for Telaprevir-Vertex Pharmaceuticals and Boceprevir-Merck Pharmaceuticals. Tina earned her Bachelors of Science in Pharmacy degree at Drake University in Des Moines, IA and holds a pharmacist license with the Florida Board of Pharmacy, Department of Health.


Eric Meyer advises emerging-stage companies launching novel consumer medical, health and wellness products. Mr. Meyer creates go-to-market strategies that integrate branding, consumer direct response (online and offline), professional recommendation and retail. Mr. Meyer’s consulting practice includes clients across a broad range of fields including sleep medicine, ENT, hearing, fitness, beauty and aesthetics. Mr. Meyer has served his clients as advisor, board member, consultant or interim executive.

Prior to his consulting practice, Mr. Meyer served as CEO of TrafficGauge Inc., which developed and brought to market the first real-time hand-held traffic map. TrafficGauge was sold to Networks In Motion in early 2009. Prior to TrafficGauge Mr. Meyer served in senior executive roles in marketing, sales, business development, and R&D for Optiva Corporation, makers of the SonicareR sonic toothbrush, over a nine year period from pre-launch through successful sale of the company to Philips Electronics. As Optiva’s 12th employee and first sales and marketing executive, Mr. Meyer led Sonicare to the #1 dollar share power toothbrush brand in the U.S., with Optiva being named Inc. Magazine’s #1 fastest growing privately-held company. Prior to Optiva, Mr. Meyer served in senior marketing and sales positions at LifeScan in Milpitas California where he launched the One Touch* blood glucose monitor. During his tenure LifeScan was successfully sold to Johnson & Johnson. Mr. Meyer has served on Boards of Directors of Orahealth Inc., Advanced H2O and Vapore Inc. Mr. Meyer holds B.S. in Industrial and Operations Engineering and Bachelor of General Studies degrees from the University of Michigan and an MBA from Stanford University.


Henry Albrecht founded Limeade in 2006, leading the company from an idea in his basement to a high-growth, SaaS health, well-being, performance and culture company. He patented the world’s first comprehensive well-being assessment with Dr. Laura Hamill. Using a values-driven approach, Henry’s created Limeade as an award-winning model employer with its engaged, high-energy and high-performing workforce. Henry’s an irreverent writer and speaker at leading national conferences discussing topics like behavioral science, well-being, employee engagement and cultural alignment. Before founding Limeade, Henry was a VP of Product Management at an enterprise software company and product marketing leader at Intuit, where he launched new multi-million dollar businesses under the QuickBooks brand. Before earning his MBA from Northwestern’s Kellogg School of Management with an emphasis in technology marketing, Henry specialized in econometrics and played professional basketball. He graduated cum laude in Literature and Economics from Claremont-McKenna College, where he was two-time basketball captain, proud winner of the Hustle Award, and a Phi Beta Kappa inductee. He lives in Bellevue with his family.


Khan Siddiqui, M.D., is a serial entrepreneur and currently the President, CTO and Chief Medical Officer of higi ( Dr. Siddiqui is responsible for strategic direction of the company and leads the team in development of higi’s products and technologies. Higi, a consumer centric health engagement company, uses a combination of interactive and social tools to help consumers easily measure and track their body, lifestyle and community. Prior to higi, he was a Physician Executive and Principal Program Manager at Microsoft responsible for platform engineering for the health solutions group. He was responsible for engineering execution on various enterprise health products as well as personal health record for consumers. One of his key achievements at Microsoft was stimulating computer vision research that led to the development of classification forest algorithm, which is the foundation technology in Xbox Kinect. Dr. Siddiqui is also a visiting Associate Professor of Radiology at John Hopkins University School of Medicine. He completed his internship at New York University followed by diagnostic radiology residency and body imaging fellowship at Geisinger Medical Center in Danville, PA as well as imaging informatics fellowship at University of Maryland.